Skip to Content
Humans and technology

The FDA Has Approved Smart Pills That Track When Patients Take Their Meds

November 14, 2017

Hope you’re comfortable swallowing your tech, because America’s first digital pill is here. The drug, called Abilify MyCite, is an antipsychotic that can be used to treat schizophrenia and some cases of bipolar disorder. But unlike regular tablets, the pills contain a small ingestible sensor to record when they’re taken.

When ingested, the sensor registers against a smart patch worn by the patient, and it transmits data to a phone. In turn—if the patient chooses—that information can be shared with medics, caregivers, or family members.

That could be particularly useful for elderly people with faltering memories, for example, to track whether they are taking their drugs. Indeed, it’s hoped that the technology will reduce the bill caused by non-adherence to prescriptions, which for the U.S. has been estimated at up to $100 billion per year.

It’s a seminal moment for digital medicine: we’ve written about such pills for at least a decade, so their approval has been a long time coming. Still, not everyone’s happy about the news. Speaking to the New York Times, psychiatrist Peter Kramer warned of privacy concerns, calling digital drugs “a potentially coercive tool.”

Deep Dive

Humans and technology

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

A new operating system for health care

A reimagined IT infrastructure for health care could reorient us from sickness to wellness.

The emergent industrial metaverse

An interface between the real and digital worlds will transform how we work, live, and interact.

How to teach kids who flip between book and screen

Technology is changing how we read—and that means we need to rethink how we teach.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.